Home-based care for lung disease in rheumatic conditions
Part of Bones, joints & muscles, Brain & nervous system, Immune system & allergy, Lungs & breathing, Skin clinical trials.
This trial tests whether people with lung disease caused by a rheumatic condition can safely manage their care at home using a smartphone or tablet. It aims to see if home monitoring is as effective as in-person visits for keeping your lungs healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a rheumatic disease like systemic sclerosis, rheumatoid arthritis, or a similar condition.
- You have been diagnosed with interstitial lung disease (ILD) on a CT scan at least one year ago.
- Your treatment for ILD or your rheumatic disease has been stable for at least six months.
- You can use a smartphone or tablet with internet access to fill out questionnaires and perform home lung tests.
- You do not have severe heart failure, severe kidney disease, or very advanced lung disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with scarring lung disease (pulmonary fibrosis) in Ireland. It aims to better understand and care for the condition, especially in families. The study will look at medical data and may help improve diagnosis and treatment.
This study tests whether people with systemic sclerosis (scleroderma) and pulmonary arterial hypertension (PAH) can safely monitor their heart health at home using a smartphone or other internet-connected device. If you have PAH and are comfortable using technology, this trial may help make care more convenient.
This trial tests whether a digital self-management program (using a smartphone or tablet) helps people with fibrotic interstitial lung disease better manage their symptoms and quality of life. If you have this lung condition and can use a mobile device, this study could offer you extra support at home.
This trial studies whether using a home monitoring program helps people with pulmonary fibrosis track their condition. It aims to make care easier and catch changes early.
This study uses remote monitoring to track patients with interstitial lung disease (ILD), a group of lung conditions. The goal is to see if monitoring from home can improve care.
This study compares a smartphone app called FORTISKAP™ that reminds you to take your medications versus standard care. The trial includes people with interstitial lung disease (a scarring condition of the lungs), sarcoidosis (an inflammatory condition), or pulmonary hypertension (high blood pressure in the lungs), and aims to see if the app helps people take their medications more reliably.
Hear when a new Dermatomyositis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.